Acrivon Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Acrivon Therapeutics by Citigroup
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $10k | 2.0k | 4.92 |
2023-09-30 | $2.2k | 230 | 9.56 |
2023-03-31 | $2.6k | 202 | 12.69 |